Jochen Gann

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Degussa Bank AG (Degussa Bank) is the investment management subsidiary of Degussa Bank Beteiligungsgesellschaft mbH in Germany. Based in Frankfurt, the firm specializes in private banking, brokerage, insurance products and retail banking for private investors. They manage mutual funds which are administered by their partner, Universal Investment GmbH.

Cognis GmbH is a supplier of specialty chemicals and nutritional ingredients. Their products are used in industrial markets encompassing home care, nutrition and health, ion-transfer technology and institutional cleaning. The company was founded in 1999 and is based in Monheim am Rhein, Germany.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Finanzierungs GmbH is a financial services provider. The company is based in Ingelheim am Rhein, Germany. The CEOs are Jochen Gann, Martin Schwarz. The German company was founded in 1968.